ULTRA-LAP Trial: Laparoscopic Debulking Surgery (LDS) in Advanced Ovarian Cancer

ULTRA-LAP is a prospective study is to investigate the safety, efficacy and feasibility of laparoscopic debulking surgery (LDS) for the treatment of patients with advanced ovarian cancer. The outcomes to measure are: * Safety: the rate of patients experiencing intra- and post-operative early and late morbidities (within the hospitalization and up to 60 days from surgery) * Efficacy: the rate of patients in which the surgical target set pre-operatively (complete resection) is achieved by laparoscopy. * Feasibility: the rate of patients who have their procedure completed by laparoscopy Patien

Trial Details

NCT ID
NCT05862740
Phase
NA
Sponsor
Azienda Ospedaliera di Padova
Status
RECRUITING
Cancer Type
Ovarian Cancer
Interventions
  • Laparoscopic Debulking Surgery in advanced ovarian cancer
  • Standard laparotomic Debulking Surgery in advanced ovarian cancer
Locations (sample)
  • Padova, Padova, Veneto, Italy|44.38225,11.14261

Key Eligibility Criteria

  • Patients with advanced epithelial ovarian cancer (II-IV Stage FIGO) candidates to PDS (primary debulking surgery) or IDS (interval debulking surger…
  • Participant is willing and able to give informed consent for participation in the study.
  • Female aged 18 years or above.
  • Primary diagnosis of advanced epithelial ovarian cancer (tubal and peritoneal cancer included).

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Ovarian Cancer Trials on Trialify →